CG:603567 Heilongjiang ZBD Pharmaceutical Co., Ltd

Heilongjiang ZBD Pharmaceutical Co., Ltd. researches, develops, produces, and sells Chinese medicines in China. It offers cardiovascular and cerebrovascular, anti-bacterial, anti-inflammatory, bone healing, detoxification, and pediatric medication drugs. The company was founded in 1996 and is based in Hulin, China.

13.28 CNY
As of 01/27/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  04/24/2015
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   12,886,068,224 CNY
Current dividend yield:   1.59%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy